Obesity modulates hematopoietic stem cell fate decision via IL-1β induced p38/MAPK signaling pathway

Jinxiao Yan,Pan Zhang,Xiru Liu,Chengwei Pan,Guolin Shi,Penghui Ye,Xiaohang Zou,Xiang Li,Xinmin Zheng,Yu Liu,Hui Yang
DOI: https://doi.org/10.1186/s13287-024-03915-w
2024-10-02
Stem Cell Research & Therapy
Abstract:Obesity is accompanied by inflammation, which significantly affects the homeostasis of the immune microenvironment. Hematopoietic stem cells (HSCs), residing primarily in the bone marrow, play a vital role in maintaining and producing diverse mature blood cell lineages for the adult hematopoietic and immune systems. However, how HSCs development is affected by obese-promoting inflammation, and the mechanism by which HSC hematopoietic potency is affected by inflammatory signals originating from the obese-promoting changes on bone marrow niche remain unclear. This study elucidates the relationship between obesity-promoting inflammation and HSC fate determination.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?